{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:53:13Z","timestamp":1789390393001,"version":"build-2803163510"},"reference-count":50,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This report explores the participation of some afferent mechanisms in the immune response induced by the Cuban anti-meningococcal vaccine VA-MENGOC-BC. The induction of delayed-type hypersensitivity in nursing babies and lymphocyte proliferation after immunization is demonstrated. The presence of gamma interferon IFN-\u03b3 and interleukin-2 (IL-2) mRNAs but absence of IL-4, IL-5, and IL-10 mRNAs were observed in peripheral blood mononuclear cells from immunized subjects after in vitro challenge with outer membrane vesicles. In addition, some effector functions were also explored. The presence of opsonic activity was demonstrated in sera from vaccinees. The role of neutrophils as essential effector cells was shown. In conclusion, we have shown that, at least in the Cuban adult population, VA-MENGOC-BC induces mechanisms with a T-helper 1 pattern in the afferent and effector branches of the immune response.<\/jats:p>","DOI":"10.1128\/iai.69.7.4502-4508.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T05:58:35Z","timestamp":1027749515000},"page":"4502-4508","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":48,"title":["Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine"],"prefix":"10.1128","volume":"69","author":[{"given":"Oliver","family":"Pe\u0301rez","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Lastre","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301","family":"Lapinet","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Bracho","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"D\u0131\u0301az","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"Zayas","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Taboada","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Sierra","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Basic and Clinical Immunology, Finlay Institute, Havana City, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3531-3536.1995"},{"key":"e_1_3_2_3_2","unstructured":"Campa H. C. Sierra V. G. VA-MENGOC-BC\u00ae. Vacuna contra la enfermedad meningoc\u00f3ccica de los grupos B y C. 1989 Centro Nacional de VAM. Ministerio de Salud P\u00fablica La Habana Cuba"},{"key":"e_1_3_2_4_2","first-page":"86","volume":"1","author":"Canadian Council on Animal Care","year":"1984","unstructured":"Canadian Council on Animal Care Guide to the care and use of experimental animals 1 1984 86 Canadian Council on Animal Care Ottawa, Ontario, Canada","journal-title":"Guide to the care and use of experimental animals"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60536-2"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.151.11.6370","article-title":"Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10","volume":"151","author":"de Waal Malefyt R.","year":"1993","unstructured":"de Waal Malefyt R. Figdor C. G. Huijbens R. Mohan-Peterson S. Bennett B. Culpepper J. Dang W. Zurawski G. de Vries J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.J. Immunol.151199363706381","journal-title":"J. Immunol."},{"key":"e_1_3_2_8_2","unstructured":"Feriol X. Graduate thesis. 1992 University of Havana Havana Cuba"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extra-neural tissues","volume":"138","author":"Fine J.","year":"1987","unstructured":"Fine J. Bitter-Suerman D. Goridis C. Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extra-neural tissues.J. Immunol.138198744024407","journal-title":"J. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.Suppl.S134"},{"key":"e_1_3_2_11_2","unstructured":"Frasch C. E. Meningococcal vaccine: past present and future p 245\u2013283.Meningococcal disease.CartwrightK.1995John Wiley & Sons Ltd.New York N.Y"},{"key":"e_1_3_2_12_2","first-page":"67","article-title":"Production, characterization and control of MenB-Vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen J. H.","year":"1991","unstructured":"Fredriksen J. H. Rosenqvist E. Wedege E. Bryn K. Bjune G. Froholm L. O. Lindbak A. K. Mogster B. Namork E. Rye U. Stabbetorp G. Winsnes R. Aase B. Closs O. Production, characterization and control of MenB-Vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease.NIPH Ann.1419916780","journal-title":"NIPH Ann."},{"key":"e_1_3_2_13_2","unstructured":"Gilman M. Ribonuclease protection assay Current protocols in molecular biology. Ausubel F. M. Brent R. Kingston R. E. Moore D. D. Seidman J. G. Smith J. A. Struhl K. 1988 4.7.1 4.7.8 John Wiley & Sons Ltd. New York N.Y"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.7.2777-2783.1992"},{"key":"e_1_3_2_17_2","unstructured":"Huergo C. C. V. G. Sierra Gonzalez M. M. Gutierrrez Vazquez G. Bisset Jorrin L. G. Garcia Imia G. de la Caridad Puentes Rizo M. del Carmen Sampedro Herrera F. Sotolongo Padron E. X. Le Riverend Morales and M. A. Galguera Dominguez. January 1997. U.S. patent 5 597 572."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(92)90022-G"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.3.877-881.1997"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05401.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.4049\/jimmunol.150.9.3728","article-title":"Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP3. Inhibition by RP3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats","volume":"150","author":"Kudo C.","year":"1993","unstructured":"Kudo C. Yamashita T. Araki A. Tershita M. Watanabe T. Atsumi M. Tamura M. Sendo F. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP3. Inhibition by RP3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats.J. Immunol.150199337283738","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","unstructured":"Lehmann A. K. Halstensen A. Sornes S. Rokke O. Waage A. High levels of interleukin 10 are associated with fatality in meningococcal disease Proceedings of the 10th International Pathogenic Neisseria Conference. Baltimore Md Zollinger W. D. Frasch C. E. Deal C. D. 1996 291 292"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.173.9.2823-2832.1991"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.2.399-410.1993"},{"key":"e_1_3_2_25_2","unstructured":"Ministerio de Salud Anuario Esta\u0131\u0301stico de Salud. 1998 Direcci\u00f3n Nacional de Estad\u0131\u0301stica del Ministerio de Salud P\u00fablica de Cuba no. 27. Ministerio de Salud P\u00fablica Havana Cuba"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cells clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mossman T. R.","year":"1986","unstructured":"Mossman T. R. Cherwinski H. Bond M. W. Giedlin M. A. Coffman R. L. Two types of murine helper T cells clone. I. Definition according to profiles of lymphokine activities and secreted proteins.J. Immunol.136198623482357","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.3.959-965.1998"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Naylor M. S. Relf M. Balkwill F. R. Northern analysis ribonuclease protection and in situ analysis of cytokine messenger RNA Cytokines: a practical approach. Balkwill F. R. 1995 35 36 Oxford University Press Oxford England","DOI":"10.1093\/oso\/9780199635672.003.0003"},{"key":"e_1_3_2_29_2","first-page":"144","article-title":"Macrophage activation by T cells","volume":"4","author":"Pailbock D. M.","year":"1992","unstructured":"Pailbock D. M. Macrophage activation by T cells.Curr. Opin. Immunol.41992144349","journal-title":"Curr. Opin. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.1.71"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/514232"},{"key":"e_1_3_2_32_2","unstructured":"Poolman J. T. Polysaccharides and membrane vaccines Bacterial vaccines. Robbins J. B. 1990 57 86 Alan R. Liss Inc. New York N.Y"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4049\/jimmunol.151.1.100","article-title":"Characterization of a novel CD2+ human thymic B cell subset","volume":"151","author":"Punnonen J.","year":"1993","unstructured":"Punnonen J. de Vries J. E. Characterization of a novel CD2+ human thymic B cell subset.J. Immunol.1511993100110","journal-title":"J. Immunol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4049\/jimmunol.152.3.1094","article-title":"IL-13 induced proliferation, Ig isotype switching and Ig synthesis by immature fetal B cells","volume":"152","author":"Punnonen J.","year":"1994","unstructured":"Punnonen J. de Vries J. E. IL-13 induced proliferation, Ig isotype switching and Ig synthesis by immature fetal B cells.J. Immunol.152199410941102","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.8.3190-3198.1993"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(91)90120-I"},{"key":"e_1_3_2_37_2","first-page":"68","article-title":"TH1 and TH2 subsets of CD4+ T lymphocytes","author":"Romagnani S.","year":"1994","unstructured":"Romagnani S. TH1 and TH2 subsets of CD4+ T lymphocytes.Sci. Am. Sci Med.May\/June19946877","journal-title":"Sci. Am. Sci Med."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5184-5190.1997"},{"key":"e_1_3_2_39_2","unstructured":"Rouppe van-der-Voort E. M. Meningococcal vaccines. A continuous crusade? Academisch Proefschrift thesis. 1998 National Institute of Public Health and the Environment Bilthoven The Netherlands"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.7.2745-2751.1996"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00401.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/593682"},{"key":"e_1_3_2_43_2","unstructured":"Sierra V. G. Campa H. C. Preclinical and clinical studies with the antimeningococcal vaccine BC: VA-MENGOC-BC \u00ae . 1990Rev. Interfer\u00f3n Biotecnol. special volume."},{"key":"e_1_3_2_44_2","unstructured":"Sierra G. V. Campa C. Garcia L. Sotolongo F. Izquierdo L. Valc\u00e1rcel M. Casanueva V. Bar\u00f3 M. Leguen F. Rodr\u0131\u0301guez R. Terry H. Efficacy Evaluation of the Cuban vaccine VA-MENGOC-BC \u00ae against disease caused by serogroup B Neisseria menigitidis .Proceedings of the 7th International Pathogenic Neisseria Conference.1990129134Walter de Gruyter & Co.Berlin Germany"},{"key":"e_1_3_2_45_2","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra V. G.","year":"1991","unstructured":"Sierra V. G. Campa C. Valc\u00e1rcel N. M. Garc\u0131\u0301a L. Izquierdo L. Sotolongo F. Casanueva V. Rico C. O. Rodr\u0131\u0301guez C. R. Terry H. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.NIPH Ann.141991195210","journal-title":"NIPH Ann."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1994.tb00433.x"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90209-3"},{"key":"e_1_3_2_48_2","unstructured":"Tappero J. Lagos R. Maldonado A. Herrera P. Gheesling L. Williams D. Carlone G. Plikaytis B. Nokleby H. Holst J. Sierra G. Perskins B. Serum bactericidal activity elicited by two outer membrane protein serogroup B meningococcal vaccines among infants pre-school children and adults in Santiago Chile.Proceedings of the 10th International Pathogenic Neisseria Conference. Baltimore MdZollingerW. D.FraschC. E.DealC. D.1996"},{"key":"e_1_3_2_49_2","unstructured":"Valc\u00e1rcel M. Almeida L. Leguen F. Sotolongo F. Izquierdo L. Campa C. Sierra V. G. Galindo A. Rodr\u0131\u0301guez R. Terry H. Epidemiological behavior of meningococcal disease in Cuba Proceedings of the 7th International Pathogenic Neisseria Conference. 1990 135 139 Walter de Gruyter & Co. Berlin Germany"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/126.5.514"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.847"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.7.4502-4508.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.7.4502-4508.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:55:13Z","timestamp":1704480913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.7.4502-4508.2001"}},"subtitle":[],"editor":[{"suffix":"Jr.","given":"W. A.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1128\/IAI.69.7.4502-4508.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.7.4502-4508.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"2000-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}